Doctor profile · Federal record
Dr. Jason Sanchez, PA-C
Physician Assistant · Medical Physician Assistant · Fresno, CA
- NPI 1871826966
- Accepts Medicare
- MIPS 0.0 / 100 · 2023
- 17 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
1290 E Spruce Ave Ste 101
Fresno, CA 937203371
(559) 431-2397
fax (559) 435-2132
Credentials & registration
- NPI registered
- September 2009 — 17 yrs on file
- Profile last updated
- May 20, 2015
- Year of graduation
- 2009 — 17 yrs since
- Specialty taxonomy
- 363A00000X — NUCC code
- State license (1)
- California #PA20499
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1871826966. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
4,490
Distinct HCPCS
10
Medicare allowed
$420,400
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 976 | 620 | $111 | |
17003 |
Destruction of precancer skin growth, 2-14 growths | 880 | 195 | $6 | |
17110 |
Destruction of skin growth, 1-14 growths | 371 | 284 | $101 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 319 | 240 | $77 | |
17000 |
Destruction of precancer skin growth, 1 growth | 316 | 254 | $44 | |
J3590 |
Unclassified biologics | 314 | 11 | $0 | |
17108 |
Destruction of birthmark, more than 50.0 sq cm | 264 | 55 | $552 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 218 | 42 | $1 | |
11102 |
Biopsy of related skin growth, first growth | 203 | 185 | $75 | |
17004 |
Destruction of precancer skin growth, 15 or more growths | 200 | 150 | $150 |
In context: peer comparison
Among 41 peers in Fresno Physician Assistant, average services per provider: 236. This provider delivers 19× the peer median.Open Payments
Industry payments received
All-time total
$4,731
Transactions
238
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Abbvie INC. | 49 | $1,050.44 | |
| Incyte Corporation | 29 | $554.48 | |
| Janssen Biotech, INC. | 29 | $313.04 | |
| Genzyme Corporation | 11 | $311.12 | |
| Ucb, INC. | 11 | $293.97 | |
| E.R. Squibb & Sons, L.L.C. | 15 | $276.86 | |
| Pfizer INC. | 9 | $242.11 | |
| Sun Pharmaceutical Industries INC. | 13 | $237.52 | |
| Lilly USA, LLC | 13 | $234.97 | |
| Amgen INC. | 10 | $232.05 | |
| Novartis Pharmaceuticals Corporation | 8 | $189.50 | |
| Dermavant Sciences, INC. | 8 | $175.66 | |
| Arcutis Biotherapeutics, INC. | 19 | $175.44 | |
| Galderma Laboratories, L.P. | 8 | $166.32 | |
| Regeneron Healthcare Solutions, INC. | 6 | $157.41 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
955
Patients
515
Total drug cost
$918,869
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Clobetasol Propionate | Generic | 142 | 82 | $13,266 |
| Ketoconazole | Generic | 137 | 73 | $3,551 |
| Fluocinonide | Generic | 91 | 67 | $7,715 |
| Doxycycline Hyclate | Generic | 77 | 41 | $4,597 |
| Cosentyx Sensoready (2 Pens) (Secukinumab) | Brand | 74 | 0 | $587,439 |
| Dupixent Pen (Dupilumab) | Brand | 72 | 0 | $270,761 |
| Clindamycin Phosphate | Generic | 58 | 30 | $2,078 |
| Tacrolimus | Generic | 55 | 38 | $19,252 |
| Mupirocin | Generic | 51 | 35 | $404 |
| Triamcinolone Acetonide | Generic | 46 | 32 | $863 |
Frequently asked questions
What is Dr. Jason Sanchez's medical specialty?
Dr. Jason Sanchez practices Physician Assistant in Fresno, CA.
Where does Dr. Jason Sanchez practice?
Dr. Jason Sanchez practices at 1290 E Spruce Ave Ste 101, Fresno, CA 937203371. Office phone: 5594312397.
What is Dr. Jason Sanchez's NPI?
Dr. Jason Sanchez's National Provider Identifier (NPI) is 1871826966, issued by NPPES.
Does Dr. Jason Sanchez accept Medicare assignment?
Yes. Dr. Jason Sanchez accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Jason Sanchez commonly perform?
Top Medicare-reported procedures in 2023: Established patient office or other outpatient visit (HCPCS 99214); Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Destruction of skin growth, 1-14 growths (HCPCS 17110). Source: CMS Medicare Physician & Other Practitioners file.